Effect of amsulpride on the improvement of cognitive function in adolescent patients with first-episode schizophrenia
10.3969/j.issn.1005-1678.2017.05.095
- VernacularTitle:氨磺必利联合奥氮平对青少年首发精神分裂症患者的临床疗效及对患者认知功能的影响
- Author:
Chengfeng LIN
;
Junxiong ZHAO
- Keywords:
first-episode schizophrenia;
tolbutamide will benefit;
olanzapine;
cognitive function;
teenagers
- From:
Chinese Journal of Biochemical Pharmaceutics
2017;37(5):287-289
- CountryChina
- Language:Chinese
-
Abstract:
Objective To investigate the efficacy of sulforubicin combined with olanzapine in the treatment of adolescents with schizophrenia and to observe its effect on cognitive function.MethodsFrom August 2013 to August 2016, 124 adolescents diagnosed with schizophrenia were randomly divided into control group and observation group,each of 62 cases.The control group was given olanzapine treatment, the observation group was given olanzapine combined with amisulpride treatment.Positive and negative symptom scale (PANSS), Wisconsin Card Sorting Test (WCST) and Wechsler Memory Scale (WMS) were used to evaluate the patient and clinical symptoms and cognitive function after 8 weeks of treatment The clinical effect and adverse changes of two groups were compared.ResultsThe PANSS score, WCST score and WMS score of the two groups were not statistically significant.After 8 weeks of treatment, the PANSS score, WCST score and WMS score of the two groups were significantly higher than those before treatment (P<0.05), and the improvement of the above scores in observation group was better than that of the control group (P<0.05).The total effective rate was 93.55% in the observation group, which was significantly higher than that in the control group (67.74%, χ2=14.49, P<0.05).There was no serious adverse reaction between the two groups.ConclusionThe combination of sulforubicin and olanzapine for the first episode of schizophrenia is very effective in improving the clinical symptoms and cognitive function of patients, and has better safety.
